164 related articles for article (PubMed ID: 16019715)
1. The double jeopardy of HDL.
Navab M; Ananthramaiah GM; Reddy ST; Van Lenten BJ; Ansell BJ; Hama S; Hough G; Bachini E; Grijalva VR; Wagner AC; Shaposhnik Z; Fogelman AM
Ann Med; 2005; 37(3):173-8. PubMed ID: 16019715
[TBL] [Abstract][Full Text] [Related]
2. High-density lipoprotein: antioxidant and anti-inflammatory properties.
Navab M; Yu R; Gharavi N; Huang W; Ezra N; Lotfizadeh A; Anantharamaiah GM; Alipour N; Van Lenten BJ; Reddy ST; Marelli D
Curr Atheroscler Rep; 2007 Sep; 9(3):244-8. PubMed ID: 18241620
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease.
Chapman MJ
Pharmacol Ther; 2006 Sep; 111(3):893-908. PubMed ID: 16574234
[TBL] [Abstract][Full Text] [Related]
4. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
Hausenloy DJ; Yellon DM
Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
[TBL] [Abstract][Full Text] [Related]
5. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.
Kontush A; Chapman MJ
Pharmacol Rev; 2006 Sep; 58(3):342-74. PubMed ID: 16968945
[TBL] [Abstract][Full Text] [Related]
6. Regulation of high-density lipoprotein by inflammatory cytokines: establishing links between immune dysfunction and cardiovascular disease.
Haas MJ; Mooradian AD
Diabetes Metab Res Rev; 2010 Feb; 26(2):90-9. PubMed ID: 20047197
[TBL] [Abstract][Full Text] [Related]
7. High-density lipoproteins, inflammation and oxidative stress.
Tabet F; Rye KA
Clin Sci (Lond); 2009 Jan; 116(2):87-98. PubMed ID: 19076062
[TBL] [Abstract][Full Text] [Related]
8. Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.
Patel S; Drew BG; Nakhla S; Duffy SJ; Murphy AJ; Barter PJ; Rye KA; Chin-Dusting J; Hoang A; Sviridov D; Celermajer DS; Kingwell BA
J Am Coll Cardiol; 2009 Mar; 53(11):962-71. PubMed ID: 19281927
[TBL] [Abstract][Full Text] [Related]
9. The role of high-density lipoprotein in inflammation.
Navab M; Anantharamaiah GM; Fogelman AM
Trends Cardiovasc Med; 2005 May; 15(4):158-61. PubMed ID: 16099381
[TBL] [Abstract][Full Text] [Related]
10. The rationale for using apoA-I as a clinical marker of cardiovascular risk.
Barter PJ; Rye KA
J Intern Med; 2006 May; 259(5):447-54. PubMed ID: 16629850
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke.
Walldius G; Jungner I
Curr Opin Cardiol; 2007 Jul; 22(4):359-67. PubMed ID: 17556890
[TBL] [Abstract][Full Text] [Related]
12. Antiinflammatory properties of HDL.
Barter PJ; Nicholls S; Rye KA; Anantharamaiah GM; Navab M; Fogelman AM
Circ Res; 2004 Oct; 95(8):764-72. PubMed ID: 15486323
[TBL] [Abstract][Full Text] [Related]
13. High-density lipoprotein mimetics: focus on synthetic high-density lipoprotein.
Shah PK
Am J Cardiol; 2007 Dec; 100(11 A):S62-7. PubMed ID: 18047855
[TBL] [Abstract][Full Text] [Related]
14. HDL function as a target of lipid-modifying therapy.
Watson KE; Ansell BJ; Watson AD; Fonarow GC
Rev Cardiovasc Med; 2007; 8(1):1-8. PubMed ID: 17401296
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
[TBL] [Abstract][Full Text] [Related]
16. Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease.
Moradi H; Pahl MV; Elahimehr R; Vaziri ND
Transl Res; 2009 Feb; 153(2):77-85. PubMed ID: 19138652
[TBL] [Abstract][Full Text] [Related]
17. Protective roles of HDL, apoA-I and mimetic peptide on endothelial function: through endothelial cells and endothelial progenitor cells.
Zhang Q; Liu L; Zheng XY
Int J Cardiol; 2009 Apr; 133(3):286-92. PubMed ID: 19068270
[TBL] [Abstract][Full Text] [Related]
18. High-density lipoprotein cholesterol-raising strategies.
Kuvin JT; Alsheikh-Ali AA; Karas RH
J Cardiovasc Pharmacol; 2006 Feb; 47(2):196-204. PubMed ID: 16495756
[TBL] [Abstract][Full Text] [Related]
19. High-density lipoproteins: marker of cardiovascular risk and therapeutic target.
Toth PP; Davidson MH
J Clin Lipidol; 2010; 4(5):359-64. PubMed ID: 21122679
[TBL] [Abstract][Full Text] [Related]
20. Beyond LDL-cholesterol: HDL-cholesterol as a target for atherosclerosis prevention.
Parhofer KG
Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):414-7. PubMed ID: 16151973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
